References
- Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand 16 March, 2020, 2020. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf. (accessed 18 March, 2020).
- Wang Y, Teunis PFM. Strongly heterogeneous transmission of COVID-19 in mainland China: local and regional variation. medRxiv 2020: 2020.03.10.20033852.
- Bialek S, Boundy E, Bowen V, et al. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. MMWR Morbidity and Mortality Weekly Report 2020; 69(12).
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
- Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Network Open 2020; 3(4): e205619-e.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020.
- National Academies of Sciences Engineering and Medicine. Rapid Expert Consultation on SARS-CoV-2 Viral Shedding and Antibody Response for the COVID-19 Pandemic (April 8, 2020). Washington, DC: The National Academies Press, 2020.
- Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020: eabb3221.
- Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020; 382(12): 1177-9.
- To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases 2020.
- Wolfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020.
- Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. American Journal of Obstetrics & Gynecology MFM 2020: 100118.
- He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020: doi: 10.1038/s41591-020-0869-5.
- Hayward M. Coronavirus: First random Covid-19 tests conducted as screening ramps up. Stuff, 19:59, Apr 16 2020, 2020. https://www.stuff.co.nz/national/health/coronavirus/121068020/coronavirus-first-random-covid19-tests-conducted-as-screening-ramps-up (accessed.
- Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect 2020.
- DeGregorio E. Questions raised over COVID-19 reinfection after Japanese woman develops illness again. Japan Times. 2020 2020/02/28.
- Hyun-ju O. 91 recovered COVID-19 patients test positive again: KCDC. Korea Herald, Apr 10, 2020 – 18:05, 2020. http://www.koreaherald.com/view.php (accessed April 11, 2020).
- Hu E. COVID-19 Testing: Challenges, Limitations and Suggestions for Improvement. Preprints 2020; 2020040155.
- Lipsitch M. Who Is Immune to the Coronavirus? New York Times. 2020 April 13, 2020.
- Traylen CM, Patel HR, Fondaw W, et al. Virus reactivation: a panoramic view in human infections. Future Virol 2011; 6(4): 451-63.
- Hopkins C, Kumar N. Loss of sense of smell as marker of COVID-19 infection. https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf
- Behrens EM. Cytokines in Cytokine Storm Syndrome. In: Cron RQ, Behrens EM, eds. Cytokine Storm Syndrome. Cham: Springer International Publishing; 2019: 197-207.
- Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. International Journal of Antimicrobial Agents 2020: 105954.
- Xu X, Han M, Li T, al e. Effective Treatment of Severe COVID-19 Patients with Tocilizumab. ChinaXiv 2020: 202003.00026v1.
- Ledford H. How does COVID-19 kill? Uncertainty is hampering doctors’ ability to choose treatments. Nature 2020; 580(7803): 311-2.
- Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International 2020.
- Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology 2020.
- Zhou B, She J, Wang Y, Ma X. The Clinical Characteristics of Myocardial injury 1 in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease. J Infect 2020.
- Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation 2020; 0(0).
- Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; n/a(n/a).
- Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020: bjophthalmol-2020-316304.
- Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51(9): 843-51.
- Du M, Cai G, Chen F, Christiani DC, Zhang Z, Wang M. Multi-omics Evaluation of Gastrointestinal and Other Clinical Characteristics of SARS-CoV-2 and COVID-19. Gastroenterology 2020.
- Yu L, Wang Z, Chen Y, et al. Clinical, Virological, and Histopathological Manifestations of Fatal Human Infections by Avian Influenza A(H7N9) Virus. Clinical Infectious Diseases 2013; 57(10): 1449-57.
- Zhan M, Qin Y, Xue X, Zhu S. Death from Covid-19 of 23 Health Care Workers in China. New England Journal of Medicine 2020.
- van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020; 382(16): 1564-7.
- Hawkes RA. Enhancement of the Infectivity of Arboviruses by Specific Antisera Produced in Domestic Fowls. Australian Journal of Experimental Biology and Medical Science 1964; 42(4): 465-82.
- Halstead SB, O’Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 1977; 146(1): 201-17.
- Halstead SB. Immune enhancement of viral infection. Prog Allergy 1982; 31: 301-64.
- Halstead SB. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 1970; 42(5): 350-62.
- Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 2011; 11(8): 532-43.
- Sanyaolu A, Okorie C, Badaru O, et al. Global epidemiology of dengue hemorrhagic fever: An update. Journal of Human Virology & Retrovirology 2017; 5(6): 00179.
- Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970; 42(5): 311-28.
- Hartmann K. Feline infectious peritonitis. Vet Clin North Am Small Anim Pract 2005; 35(1): 39-79, vi.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
- Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA 2020.
- Donovan J. Social-media companies must flatten the curve of misinformation. Nature 2020.
- Broad WJ. Putin’s Long War Against American Science. New York Times. 2020 April 13, 2020.
About the Briefing
Public health expert commentary and analysis on the challenges facing Aotearoa New Zealand and evidence-based solutions.
Subscribe
Public Health Expert Briefing
Get the latest insights from the public health research community delivered straight to your inbox for free. Subscribe to stay up to date with the latest research, analysis and commentary from the Public Health Expert Briefing.